Bausch Health Companies Inc. (BHC)

Trade BHC now with
5/9/2019 8:12:54 AM Bausch Health Companies Plans Private Offering Of Senior Notes
4/29/2019 8:09:04 AM Bausch + Lomb Says New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented
4/25/2019 7:17:50 AM Salix, Mitsubishi Tanabe To Develop Late Stage Investigational S1P Modulator For Inflammatory Bowel Disease
4/2/2019 7:07:38 AM Bausch + Lomb Announces U.S. Launch Of LOTEMAX SM 0.38% For Postoperative Inflammation, Pain Following Ocular Surgery
4/1/2019 7:22:47 AM Salix Pharma, California Univ. To Develop Compound For Treatment Of Non-alcoholic Fatty Liver Disease, Steatohepatitis
3/8/2019 7:03:38 AM Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers
3/6/2019 9:04:42 AM Bausch Health Closes Acquisition Of Certain Assets Of Synergy Pharma
2/26/2019 7:42:51 PM Bausch Health Selected As Successful Bidder To Buy Certain Assets Of Synergy Pharma For $195 Mln And Assumption Of Debt
2/25/2019 7:06:24 AM Bausch + Lomb Announces FDA Approval Of LOTEMAX SM 0.38% For Postoperative Inflammation And Pain
2/22/2019 7:42:55 AM Bausch Health Begins Cash Tender Offers And Consent Solicitation For Up To $1.25 Bln Aggregate Purchase Price
2/20/2019 7:04:19 AM Bausch Health Companies Q4 Total Reported Revenues Down 2% To $2.121 Bln
2/19/2019 7:08:14 AM Bausch Health Buys Eton Pharma' EM-100 Investigational Eye Drop For Treatment Of Itchy Eyes Associated With Allergies
2/13/2019 8:12:24 AM Bausch + Lomb Gets 510(k) Clearance For Use Of TangibleĀ® Hydra-PEG Custom Contact Lens Coating Tech
1/3/2019 7:38:11 AM Bausch + Lomb Announces HEALTH CANADA Approval Of VYZULTA For Glaucoma